---
title: "Adline Chem Lab Ltd (524604) — Share Price, Financials & Analysis"
symbol: "524604"
company: "Adline Chem Lab Ltd"
canonical: "https://tapetide.com/stocks/524604"
isin: "INE276T01018"
nse_symbol: "KAMRONLABORATORIESLTD"
bse_code: "524604"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 6.7
generated_at: "2026-09-13T19:38:34.227Z"
---

# Adline Chem Lab Ltd (524604)

Canonical page: https://tapetide.com/stocks/524604

## Company

- **NSE Symbol:** KAMRONLABORATORIESLTD
- **BSE Code:** 524604
- **ISIN:** INE276T01018
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** kamronlabs.com

## About

Incorporated in 1988, Adline Chem Lab Ltd trades in pharmaceutical formulations, Nutraceutical, and Dietary products.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:35:49.553187Z.

- **Market Cap:** ₹6.7 Cr
- **Classification:** Microcap
- **P/E (reported):** -36
- **EPS (TTM):** ₹-0.3
- **Book Value:** ₹-3.03
- **Price to Book:** -3.8
- **Dividend Yield:** 0%
- **ROE:** 15.84%
- **ROCE:** -393.8%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹0 Cr
- **Net Income:** ₹-0.3 Cr
- **EBITDA:** ₹-0.2 Cr
- **52-Week High:** ₹17.06
- **52-Week Low:** ₹7.6
- **RSI (14):** 16.68

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding is low: 25.8%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 30.43% | 5.88% | -176.19% |
| ebitda margin growth | 200% | — | -99.01% | — |
| net income growth | 100% | 200% | 0% | 12% |
| revenue growth | 0.1% | -100% | — | -100% |
| roce | — | 426.26% | — | -20.12% |
| roe | — | 78.98% | 14.83% | -41.55% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.03 | 0 | 0.07 | 0.1 | 0.07 | 0.1 | 0.06 | 0.03 | 0.05 | 0.03 | 0.08 | 0.04 |
| Operating Profit | -0.03 | 0 | -0.07 | -0.1 | -0.07 | -0.1 | -0.06 | -0.03 | -0.05 | -0.03 | -0.08 | -0.04 |
| Other Income | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.25 | 0 | 0 | 0 | 0.01 | 0.12 |
| Interest | 0.03 | 0.03 | 0 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.06 | -0.03 | -0.04 | -0.13 | -0.1 | -0.13 | 0.16 | -0.06 | -0.08 | -0.07 | -0.11 | 0.03 |
| Tax % | -16.67 | -33.33 | 0 | -7.69 | -10 | -7.69 | -31.25 | -16.67 | -12.5 | -14.29 | -9.09 | -33.33 |
| Net Profit | -0.05 | -0.02 | -0.04 | -0.13 | -0.09 | -0.12 | 0.21 | -0.05 | -0.07 | -0.06 | -0.09 | 0.04 |
| EPS in Rs | -0.09 | -0.03 | -0.07 | -0.22 | -0.15 | -0.21 | 0.36 | -0.09 | -0.12 | -0.1 | -0.15 | 0.07 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 8.1 | 5.59 | 6.59 | 6.33 | 0.74 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 7.23 | 5.01 | 9.91 | 6.56 | 1.04 | 0.8 | 0.18 | 0.3 | 0.2 | 0.2 |
| Operating Profit | 0.87 | 0.58 | -3.32 | -0.23 | -0.3 | -0.8 | -0.18 | -0.3 | -0.2 | -0.2 |
| OPM % | 10.74 | 10.38 | -50.38 | -3.63 | -40.54 | — | — | — | — | — |
| Other Income | 0.21 | 0.25 | 0.26 | 0 | 1.33 | -3.35 | 0 | 0.25 | 0.01 | 0.13 |
| Interest | 0.34 | 0.07 | 0.02 | 0.03 | 0.01 | 0 | 0.12 | 0.16 | 0.13 | 0.16 |
| Depreciation | 0.73 | 0.73 | 0.42 | 1.02 | 0.35 | 0.09 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.01 | 0.03 | -3.5 | -1.28 | 0.67 | -4.24 | -0.3 | -0.21 | -0.32 | -0.23 |
| Tax % | 100 | 0 | 7.43 | 0 | -7.46 | 0 | -10 | -33.33 | -12.5 | — |
| Net Profit | 0 | 0.03 | -3.76 | -1.28 | 0.72 | -4.23 | -0.27 | -0.13 | -0.28 | -0.18 |
| EPS in Rs | 0 | 0.05 | -6.43 | -2.19 | 1.23 | -7.23 | -0.46 | -0.22 | -0.48 | -0.3 |
| Dividend Payout % | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 |
| Reserves | 1.19 | 1.18 | 1.18 | -2.64 | -3.92 | -3.2 | -7.42 | -7.22 | -7.34 | -7.62 |
| Borrowings | 9.94 | 11.32 | 5.35 | 2.85 | 2.5 | 1.32 | 1.33 | 1.36 | 1.49 | 1.8 |
| Other Liabilities | 3.97 | 5.01 | 9.46 | 1.52 | 1.2 | 0.91 | 0.31 | 0.06 | 0.08 | 0.04 |
| Total Liabilities | 20.95 | 23.36 | 21.84 | 7.58 | 5.63 | 4.88 | 0.07 | 0.05 | 0.08 | 0.07 |
| Fixed Assets | 12.68 | 12.45 | 11.99 | 4.78 | 3.64 | 4.43 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8.27 | 10.91 | 9.85 | 2.8 | 1.99 | 0.45 | 0.07 | 0.05 | 0.08 | 0.07 |
| Total Assets | 20.95 | 23.36 | 21.84 | 7.58 | 5.63 | 4.88 | 0.07 | 0.05 | 0.08 | 0.07 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2.46 | 0.89 | -0.95 | -11.34 | -0.29 | 0.21 | 0.01 | -0.17 | -0.23 | -0.16 |
| Cash from Investing Activity | -3.18 | -0.37 | -0.28 | 11.24 | 0.12 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 0.63 | 1.04 | -0.29 | -0.02 | -0.03 | -0.01 | 0 | 0.15 | 0.25 | 0.16 |
| Net Cash Flow | -0.09 | 1.56 | -1.51 | -0.12 | -0.21 | 0.2 | 0.01 | -0.02 | 0.02 | 0 |
| Free Cash Flow | -0.73 | 0.36 | -1.23 | -0.1 | -0.17 | 0.21 | 0.01 | -0.17 | -0.23 | -0.16 |
| CFO/OP | 203 | 102 | -164 | 342 | 126 | -70 | -1 | 94 | 110 | 80 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 56.3 | 102.74 | 135.81 | 79.2 | 91.11 | 34.53 | — | — | — | — |
| Inventory Days | 55.54 | 181.31 | 832.82 | 81.53 | 46.98 | 197.71 | 0 | — | — | — |
| Days Payable | 49.24 | 63.34 | 436.97 | 41.89 | 28.91 | 342.19 | — | — | — | — |
| Cash Conversion Cycle | 62.6 | 220.71 | 531.66 | 118.84 | 109.18 | -109.95 | — | — | — | — |
| Working Capital Days | -29.53 | -139.69 | -317.99 | -72 | -66.89 | -764.53 | — | — | — | — |
| ROCE % | 2 | 1.98 | 0.59 | -40.35 | -23.83 | -10.95 | 5.9 | — | — | -1266.67 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 28.24% | 28.24% | 29.61% | 29.61% | 29.61% | 29.61% | 29.61% | 29.61% | 29.61% | 25.85% | 25.85% | 25.85% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 61.53% | 61.63% | 60.29% | 60.3% | 60.32% | 60.15% | 60.13% | 60.16% | 60.16% | 63.92% | 63.99% | 63.71% |
| Others | 10.23% | 10.14% | 10.1% | 10.09% | 10.07% | 10.24% | 10.26% | 10.23% | 10.23% | 10.22% | 10.16% | 10.43% |
| No. of Shareholders | 18638 | 18628 | 18595 | 18583 | 18536 | 18509 | 18514 | 18481 | 18488 | 18468 | 18446 | 18444 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 11.83 | Sell |
| EMA (10) | 12.15 | Sell |
| SMA (20) | 12.29 | Sell |
| EMA (20) | 12.63 | Sell |
| SMA (50) | 13.21 | Sell |
| EMA (50) | 13.07 | Sell |
| SMA (100) | 13.31 | Sell |
| EMA (100) | 13.54 | Sell |
| SMA (200) | 14.95 | Sell |
| EMA (200) | 14.42 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.12 | Neutral |
| MACD (12,26,9) | -0.56 | Sell |
| Stochastic (14,3,3) | 28.92 | Neutral |
| ADX (14) | 10.27 | Neutral |
| Williams %R (14) | -80.04 | Buy |
| ATR (14) | 1.83 | High Volatility |
| ROC (12) | -11.52 | Sell |
| Stoch RSI (14) | 27.43 | Neutral |
| UO (7,14,28) | 46.72 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ca3c240-8953-4b56-951f-71507e0bf9a4.pdf) |
| 2026-09-03 | [Notice Of 38Th Annual General Meeting Of Adline Chem Lab Limited Scheduled To Be Held On Monday September 28 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d928dfe-1c5e-485c-8b94-329f0c363ba7.pdf) |
| 2026-09-03 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f78f11f9-66a1-4b72-9ef9-79141e77484a.pdf) |
| 2026-09-01 | [Board Meeting Outcome for Outcome For Board Of Directors Meeting Held On Tuesday 01St September 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3ee299c-eb9d-44d3-acac-1ad757a2af8f.pdf) |
| 2026-08-27 | [Board Meeting Outcome for Board Of Directors Meeting Held On Thursday 27Th August 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59536b30-44d9-4538-a568-a5be54ac10da.pdf) |
| 2026-08-24 | [Board Meeting Intimation for 38Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91607ded-b395-4d35-8845-aaa0d5f68f55.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a42d112e-2a7b-4412-83ef-2d09cec86789.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Board Meeting Outcome For Adline Chem Lab Limited For Unaudited Standalone Financial Results For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2911ee83-defa-42b9-97a1-8d1ce4a60795.pdf) |
| 2026-08-10 | [Board Meeting Intimation for For Considering And Approving Un-Audited Standalone Financial Results For The Quarter Ended On 30.06.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc7994ff-ba84-4cf4-8eef-659f165d52ad.pdf) |
| 2026-07-15 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6c8b5b0-e7ce-4a57-aeab-3f795813414f.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c280d476-b9ed-4997-ace1-40bd162ae696.pdf) |
| 2026-05-29 | [Financial Results For 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6122a07c-63fc-4cfe-a3ec-1d4ee36e1b6c.pdf) |
| 2026-02-10 | [UNAUDITED FINANCIAL RESULTS (STANDALONE) FOR THE THIRD QUARTER AND NINE MONTHS ENDED DECEMBER 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b877b669-69dc-4ccc-863e-014b54412d42.pdf) |
| 2025-11-12 | [Unaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaec0d6a-79e7-482e-9759-0d3208e4f19b.pdf) |
| 2025-08-12 | [Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d342f652-3af6-431c-89ea-08fa1609a65c.pdf) |
| 2025-05-09 | [Financial Results For March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9c19467-53aa-41cf-84a6-a41d2ae08bab.pdf) |
| 2025-02-04 | [Results For Quarter And Nine Months Ended On 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81e72204-6da3-4ec0-b4ee-58e4b97d8926.pdf) |
| 2024-11-13 | [Results For Financial Results For Quarter And Half Year Ended 30Th September, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e922f8e3-24cb-454e-8a21-15ade2faa77c.pdf) |
| 2024-05-23 | [Outcome Of Board Meeting Held Today I.E., 23Rd May, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17c8989c-fa87-4365-8545-84870cf5f243.pdf) |
| 2024-01-25 | [Results - Financial Results For 31St December, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a2535d-7a62-4f02-b890-b8e304e9ca0b.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 30 Jan - Digitide uploaded Q3 FY26 earnings conference call audio on company website on January 30, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Jan - Digitide uploaded Q3 FY26 earnings conference call audio on company website on January 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a438ce8f-dbf7-4870-abbd-d0ab233d888e.pdf) |
| 30 Apr - Company confirms it is not a Large Corporate; annual disclosure not required for FY2026. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Company confirms it is not a Large Corporate; annual disclosure not required for FY2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d0f9baa2-e9cb-46d0-80d5-156281ee3484.pdf) |
| 30 Apr - Company confirms it is not a Large Corporate; annual disclosure not required for FY2026. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Company confirms it is not a Large Corporate; annual disclosure not required for FY2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d0f9baa2-e9cb-46d0-80d5-156281ee3484.pdf) |
| 30 Apr - Adline Chem Lab confirms it is not a Large Corporate; outstanding borrowing was Rs. 1.73 crore on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Adline Chem Lab confirms it is not a Large Corporate; outstanding borrowing was Rs. 1.73 crore on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c1ec139-2530-4dfd-95d2-cd55f7884fdb.pdf) |
| 30 Apr - Adline Chem Lab confirms it is not a Large Corporate; outstanding borrowing was Rs. 1.73 crore on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Adline Chem Lab confirms it is not a Large Corporate; outstanding borrowing was Rs. 1.73 crore on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6c1ec139-2530-4dfd-95d2-cd55f7884fdb.pdf) |
| 29 Jan - Board approved Q3/9M FY26 results (Consol revenue INR 7,803m); ESOS 4,965,568 options (3.33%), shareholder approval pending. | [Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On January 29, 2026 29 Jan - Board approved Q3/9M FY26 results (Consol revenue INR 7,803m); ESOS 4,965,568 options (3.33%), shareholder approval pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/59514ce3-5bd0-49f7-871b-4caa0deae487.pdf) |
| 29 Apr - Adline Chem Lab says annual secretarial compliance report not applicable for FY2026 under SEBI exemption. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 29 Apr - Adline Chem Lab says annual secretarial compliance report not applicable for FY2026 under SEBI exemption.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14d23441-1889-4bcb-a356-dd7871edc53e.pdf) |
| 29 Apr - Adline Chem Lab says annual secretarial compliance report not applicable for FY2026 under SEBI exemption. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 29 Apr - Adline Chem Lab says annual secretarial compliance report not applicable for FY2026 under SEBI exemption.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/14d23441-1889-4bcb-a356-dd7871edc53e.pdf) |
| 27 Apr - Shareholders approved appointment of Vrushank Balkrushna Patel as Chairman and Managing Director via postal ballot. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 27 Apr - Shareholders approved appointment of Vrushank Balkrushna Patel as Chairman and Managing Director via postal ballot.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/be8e7fe6-f40d-4991-a611-1602448ab884.pdf) |
| 25 Mar - Newspaper Advertisement with respect to Postal Ballot Notice and remote e-voting. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 25 Mar - Newspaper Advertisement with respect to Postal Ballot Notice and remote e-voting.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f14b31d4-a51c-426c-af7e-b6a0142fcd6e.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3d678f66-0c94-4863-b077-2537104ad622.pdf) |
| Jul 2025 | [Concall - Jul 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f66fdb22-62f9-45c3-a05c-97f561d3b090.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/329144f9-02dd-4d08-a5a3-6f98b174daed.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/46fc00ed-7c14-425b-86cd-3f18e4ab8b23.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/82d9fbb0-0912-473c-8d21-483e7b243784.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e7d8098c-5b1c-472b-84e0-1ea9223b7a0c.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d992b9e-6ae6-43bb-9df7-b2d7eeabde57.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524604/74467524604.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524604/69578524604.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524604/65314524604.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524604/5246040319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524604/5246040318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/524604/5246040317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:38:34.227Z.